nach oben

memo - Magazine of European Medical Oncology

Erschienen in:

01.05.2024 | editorial

Rare lung cancer special: a multifaceted approach

verfasst von: Ass. Prof. PD. Dr. Andreas Pircher, PhD

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Auszug

In the diagnostic and treatment landscape of lung cancers, rare tumors represent a major challenge for patient management in terms of their biology, classification, clinical behavior. Here we present five articles that collectively illustrate the complexity of rare lung cancer subtypes, diagnosis and personalized treatment approaches. …

Vorheriger Artikel Congress update 2023—ASCO and ESMO

Nächster Artikel Antibody–drug conjugates (ADC special)—part 1

Wang C, Zhang R, Xiaorong S, Xing XSL. Prediction of epidermal growth factor receptor mutation status by textural features in stage IV lung adenocarcinoma. memo. 2024;17(2):961–961. https://doi.org/10.1007/s12254-024.CrossRef

Müser NR, Kirchbacher K, Funk G‑C. Transformation of epidermal growth factor receptor-mutated non-small cell lung cancer into small cell lung cancer—case report. memo. 2024;17(2):953–7. https://doi.org/10.1007/s12254-023.CrossRef

Olteanu GE, Brcic L. Pulmonary Puzzles: Salivary Gland-Type Tumors of the Lung and Their Metastatic. memo. 2024;17(2):957–953. https://doi.org/10.1007/s12254-023.CrossRef

Sharapova Y, Loges S, Janning M. Rare oncogenic alterations in NSCLC – focus on atypical EGFR mutations. memo. 2024;17(2):960–2. https://doi.org/10.1007/s12254-024.CrossRef

Heidenreich A, Pfaffenholz P, Pfister D. Diagnosis and Management of mediastinal extragonadal germ cell tumors. memo. 2024; https://doi.org/10.1007/s12254-023-00941-x.CrossRef

Titel: Rare lung cancer special: a multifaceted approach
verfasst von: Ass. Prof. PD. Dr. Andreas Pircher, PhD
Publikationsdatum: 01.05.2024
Verlag: Springer Vienna
Erschienen in: memo - Magazine of European Medical Oncology / Ausgabe 2/2024
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-024-00970-0

Prediction of epidermal growth factor receptor mutation status by textural features in stage IV lung adenocarcinoma

original report

Pulmonary puzzles: salivary gland-type tumors of the lung and their metastatic equivalents

Open Access
short review

Transformation of epidermal growth factor receptor-mutated non-small cell lung cancer into small cell lung cancer—case report

case report

Congress update 2023—ASCO and ESMO

editorial

ASCO 2023: highlights in breast cancer

Open Access
short review

Upper-GI highlights from ASCO and ASCO-GI 2023 meetings: changing paradigm in treatment sequence

Open Access
short review

Springer Medizin Österreich

Rare lung cancer special: a multifaceted approach

Auszug

Weitere Artikel der Ausgabe 2/2024

Prediction of epidermal growth factor receptor mutation status by textural features in stage IV lung adenocarcinoma

Pulmonary puzzles: salivary gland-type tumors of the lung and their metastatic equivalents

Transformation of epidermal growth factor receptor-mutated non-small cell lung cancer into small cell lung cancer—case report

Congress update 2023—ASCO and ESMO

ASCO 2023: highlights in breast cancer

Upper-GI highlights from ASCO and ASCO-GI 2023 meetings: changing paradigm in treatment sequence

Springer Medizin Österreich

Auszug

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Prediction of epidermal growth factor receptor mutation status by textural features in stage IV lung adenocarcinoma

Pulmonary puzzles: salivary gland-type tumors of the lung and their metastatic equivalents

Transformation of epidermal growth factor receptor-mutated non-small cell lung cancer into small cell lung cancer—case report

Congress update 2023—ASCO and ESMO

ASCO 2023: highlights in breast cancer

Upper-GI highlights from ASCO and ASCO-GI 2023 meetings: changing paradigm in treatment sequence